Introduction
Cancer develops as a result of multiple genetic and epigenetic alterations. Functional imbalances between oncogenes and tumor suppressor genes have been identified in most types of cancer, including gastric cancer (1) . Better knowledge of the changes in gene expression that occur during gastric carcinogenesis may lead to improvements in diagnosis, treatment and prevention of gastric cancer (2) . Increasing evidence shows that there are disorders of signaling pathways and disequilibria between oncogenes and tumor suppressor genes in the occurrence and development of gastric cancer (3, 4) . The homeostatic self-renewal of the stomach depends on a complex interplay between processes involved in cell proliferation, differentiation, migration, adhesion and cell death (5) . This panoply of cellular responses is coordinated by a relatively small number of highly conserved signaling pathways, which include the bone morphogenetic protein (BMP) (6, 7) , Sonic Hedgehog (8) , Notch (9) and Wnt (10) signaling pathways. Deregulation of these pathways may lead to pathological conditions, such as cancer. This notion is particularly well-illustrated by the role of the Notch and Wnt pathway in the gastric mucosa cells (11) .
The Notch signaling pathway is a highly conserved signaling system in mammals, which has been found to play central roles in stem cell maintenance, cell fate decisions, as well as cancer in humans (12, 13) . Notch receptors are single-span membrane proteins (Notch1-4 in mammals). The ligands for Notch are similar but smaller single-pass transmembrane proteins, consisting of three δ-like proteins (DLL-1, -3 and -4) and two Jagged proteins (JAG-1 and -2) (14, 15) . Binding to Notch by ligand on an adjacent cell triggers two enzymatic cleavages of Notch, extracellularly by an α-secretase (a disintegrin and metalloprotease ADAM-10 and ADAM-17) and intracellularly by the γ-secretase/presenilin complex. The liberated Notch intracellular domain (NICD) then travels to the nucleus, displaces corepressors from CBF1/ Suppressor of hairless/LAG-1 (CSL) transcription factors, and recruits coactivators such as histone acetyl-transferase and Mastermind-like to activate downstream target genes such as the Hes and Hey gene families (16) (17) (18) . A number of relevant studies have showed that the expression levels of the Notch signaling pathway components change in gastric cancer tissues (9, 12) . However, there is not a final conclusion about whether it plays a cancer-suppressor or a cancer-promoting role on the occurrence and development of gastric cancer.
The classic Wnt/β-catenin signaling pathway is also known to play a critical role on cell proliferation and homeostasis. In the absence of Wnt signals, free cytoplasmic β-catenin is actively targeted for degradation. This is accomplished by glycogen synthase kinase-3β (GSK-3β) and two scaffolding proteins, the tumor suppressors adenomatous polyposis coli (APC) and Axin/Axin2, in the so-called destruction complex. Thus, β-catenin is not able to accumulate excessively (19) . The binding of Wnt ligands to corresponding frizzled receptors induces the excessive accumulation of β-catenin in the cytoplasm (20, 21) . Then, the β-catenin translocates into the nucleus and binds to the lymphoid enhancer factor (LEF)/T cell factor (TCF) families and activates downstream target genes such as c-Myc and cyclin D1 (22, 23) . Previous studies have demonstrated that aberrant Wnt/c-Myc-catenin signaling is detected in a wide variety of human tumors, including breast cancer, melanoma and colon cancer (24) (25) (26) . Sergio and Kalaska (27) also confirmed that the expression changes of the Wnt/β-catenin signaling pathway occur in gastric cancer tissues, as well as the correlation with clinical stages and the degrees of differentiation of gastric cancer.
In the present study, we co-activated the Notch and Wnt signaling in BGC-823 human gastric cancer cells and investigated the effects of this co-activation on the proliferation of tumor cells and the possible underlying mechanism.
Materials and methods
Cell line and culture. Human gastric carcinoma BGC-823 cells (China Center for Type Culture Collection, Wuhan University, Hubei, China) were cultured in RPMI-1640 medium (Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Sigma, St. Louis, MO, USA), 100 U/ml penicillin and 100 µg/ml streptomycin. All the cells were cultured in a humidified environment (37˚C and 5% CO 2 ). BGC-823 cells were treated using Notch1 signaling pathway activator doxycycline (Promega, Madison, WI, USA) and Wnt/β-catenin signaling pathway activation agent LiCl (Amresco, Solon, OH, USA) for up to 48 h.
Western blot analysis. Cells were lysed using RIPA (1% SDS, 5% sodium deoxycholate, 1% NP-40, 0.1% PMSF) and protein was determined according to the Lowry method. Equal amounts of proteins were separated in 10% SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride membranes. The membranes were blocked by 3% bovine serum albumin (BSA) in the Tris-buffered saline with Tween-20 (TBST) for 2 h at room temperature and then incubated with primary antibodies (Abcam, Cambridge, MA, USA) at 4˚C overnight. The corresponding horseradish peroxidase-conjugated secondary antibodies were incubated for 2 h at room temperature. The protein bands were determined by electrochemical luminescence (ECL) and exposed by GeneGenius automatic gel imaging system (Syngene, Cambridge, UK). The experiment was repeated 3 times independently.
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay.
BGC-823 cells were seeded in 96-well microplates at a density of 0.2x10 4 /well for 0, 12, 24, 36 and 48 h, respectively. MTT solution (20 µl; 5 mg/ml) was added into every well. Cells were cultured at 37˚C and 5% CO 2 for 4 h, followed by the addition of 100 µl of solubilization solution into each well. The plates were kept in a dark room overnight, and the absorbance (A) at 570 nm was read by a Tecan Sunrise (Tecan, Männedorf, Switzerland).
Transmission electron microscopy. The 5-mm 3 cells lumps generated by centrifugation were soaked in the 2.5% glutaraldehyde solution for 12 h, washed using 0.1 mol/l phosphate-buffered saline (PBS) three times and kept in PBS overnight at 4˚C. Then, the lumps were soaked in 1% osmium tetroxide acid (OsO 4 ) for 2 h and washed again, and incubated at 4˚C overnight. The cells lumps were dehydrated with ethanol solutions step by step for 15 min. Following dehydration, the lumps were washed by acetone twice, then soaked in the fluid which was mixed with the resin and an equal volume of acetone for 2 h, and then soaked in pure resin overnight. Following embedding, cells lumps were incubated at 37˚C, 45˚C, 60˚C respectively for 24 h. The lumps were fixed into pyramid shape to be cut into ultra-thin slices using the UC6 ultrathin slice machine (Leica, Wetzlar, Germany). The slices in nets were dyed and observed using transmission electron microscope (Carl Zeiss, Oberkochen, Germany).
Flow cytometry. BGC-823 cells were collected after various treatments by trypsinization, washed with PBS, fixed overnight in 70% ethanol at 4˚C, incubated for 30 min with 40 µg propidium iodide (PI, Sigma) and 100 µg RNase A (Sigma) in PBS and analyzed on a FACSCalibur flow cytometer (Becton-Dickinson, Mountain View, CA, USA). Collected data were analyzed by CellQuest Pro Analysis software.
Statistical analysis. Each group of experiments was repeated at least three times. Data were evaluated using the Statistics Software Package (Student's t-test or analysis of variance). P<0.05 was considered to indicate a statistically significant difference. 
A B Results

Activation of Notch and Wnt signaling pathways.
BGC-823 cells were harvested at 24 h after treatment with different concentrations of LiCl and doxycycline. Western blot analysis showed that β-catenin and Notch1 were expressed in an activator concentration-dependent manner, and that β-catenin or Notch1 proteins were significantly increased by 10 mmol/l LiCl or 1 µg/ml doxycycline, respectively (Fig. 1) . Compared with the control, cell proliferation was significantly inhibited when the Notch1 signaling pathway was activated, while cell proliferation was enhanced when the Wnt/β-catenin signaling pathway was activated or when the Wnt and Notch pathways were coactivated (Fig. 2) .
Expression of key components of two signaling pathways in BGC-823 cells.
Firstly, the protein expression of Notch1 and the Notch target gene Hes1 were measured by western blot analysis using polyclonal antibodies against Notch1 (including epitopes of NICD) and Hes1. Upon activation of the Notch1 pathway by doxycycline or the activation of both Notch1 and Wnt pathways by doxycycline and LiCl, the expression of Notch1 and Hes1 was significantly increased compared with the control, while it was reduced in LiCl-treated cells (Fig. 3A) . Secondly, the protein expression of β-catenin and cyclin D1 in single or both activator-treated cells were detected. The expression levels of β-catenin and cyclin D1 were significantly increased in doxycycline-treated and co-activated cells (Fig. 3B) .
Ultrastructural alterations of BGC-823 cells under Wnt and
Notch co-activation. When Notch1 signaling was activated, the cell membrane microvilli were reduced, the nucleus atrophied and some vacuoles were observed in the cytoplasm of (Fig. 4B) . These data suggest that cell necrosis occurred when the Notch1 pathway was activated. When Wnt or both Wnt and Notch pathways were activated, we found that the membrane microvilli were developed, and that a limited number of vacuoles was observed in the cytoplasm ( Fig. 4C and D). Cell membrane microvilli were developed and the organelles were normal. The nucleolus was clear in the control (Fig. 4A) .
Cell cycle analysis of BGC-823 cells when Notch and Wnt were co-activated.
Compared with the control, G 1 /S transition was blocked when Notch1 signaling was activated, while G 1 /S transition was promoted when Wnt/β-catenin signaling was activated. The proportion of the cells in S phase in the coactivated cells was higher compared with the control, while lower than the group in which only the Wnt/β-catenin signaling was activated (Fig. 5) .
Expression of CDK2, cyclin E and c-Myc in BGC-823 cells under Wnt and Notch co-activation.
The expression of cyclin E, CDK2 and c-Myc in activation of Notch1 signaling were significantly lower compared with the control, suggesting that Notch1 signaling inhibits cell proliferation by blocking the G 1 /S transition. When the Wnt pathway was activated by LiCl, the expression of cyclin E, CDK2 and c-Myc was significantly increased, suggesting that Wnt/β-catenin signaling promotes BGC-823 cell proliferation by advancing G 1 /S transition and accelerating the cell cycle process. When both Wnt and Notch1 were activated, the expression levels of cyclin E, CDK2 and c-Myc were significantly increased compared with the control, while they were lower compared with the expression levels when only the Wnt pathway was activated, suggesting that the Wnt/β-catenin signaling had a certain antagonistic effect on Notch1 signaling (Fig. 6) .
Discussion
In the present study, the effects of the activation of Notch1 pathway by doxycycline, the activation of Wnt pathway by LiCl and the co-activation of the two pathways were observed in BGC-823 cells. It was found that the activation of Wnt signaling overcomes the pro-apoptotic role of Notch in gastric cancer cells.
Firstly, the two pathways were triggered using doxycycline and LiCl, respectively. Treatment with doxycycline, an activator of the Notch1 signaling pathway, resulted in higher expression levels of the Notch1 and Hes1 proteins. Treatment with LiCl, an activator of the Wnt/β-catenin signaling pathway, resulted in higher expression levels of the β-catenin and cyclin D1 proteins. CDK2-cyclin E complexes, phosphorylating the retinoblastoma protein, drive cells into the S phase of the cell cycle. The proto-oncogene c-Myc protein promotes cell proliferation and induces cytologic atypia, through binding to the specific DNA sequence. c-Myc also has a close association with the G 1 /S transition.
Compared with the control, when only the Notch1 signaling pathway was activated, the expression of β-catenin and cyclin D1 were stable, while the expression of cyclin E, CDK2 and c-Myc decreased, suggesting that the Notch1 signaling pathway had no marked effect on the Wnt/β-catenin signaling pathway. The inhibition of cyclin E, CDK2 and c-Myc resulted in cell cycle retardation and inhibited the proliferation of BGC-823 cells. When only the Wnt/β-catenin signaling pathway was activated, the expression of Notch1 and Hes1 significantly decreased, while the expression of cyclin E, CDK2 and c-Myc increased, suggesting that the Notch1 signaling pathway may be regulated to some extent by the Wnt/β-catenin signaling pathway. Previous studies have shown that Dsh has an antagonistic effect on the Notch1 signaling pathway by binding to the intracellular domain of Notch1 (28) . The high levels of cyclin D1, cyclin E, CDK2 and c-Myc promote G 1 /S transition and the cell proliferation of BGC-823 cells. When the Notch1 and Wnt/β-catenin signaling pathways were simultaneously activated, the expression of Notch1 and Hes1 was higher compared with the control, while it was lower compared with the group in which only the Notch1 signaling pathway was activated. The expression of β-catenin and cyclin D1 was higher compared with the control, while it was not different when only the Wnt/β-catenin signaling was significantly activated. The expression levels of cyclin E, CDK2 and c-Myc were higher compared with the control, suggesting that the activated Wnt/β-catenin signaling pathway was able to overcome the inhibitory effects of the Notch1 signaling pathway on cyclin E, CDK2 and c-Myc.
In conclusion, it was found that the Notch1 signaling pathway plays an inhibitory role in the process of BGC-823 cell development. The activated Notch1 signaling inhibits the proliferation of BGC-823 cells by the downregulation of c-Myc, cyclin E and CDK2, while the highly regulated Wnt signaling cascade plays a key role during BGC-823 cell development. The activated Wnt/β-catenin signaling promotes the proliferation of BGC-823 cells by the upregulation of c-Myc, cyclin D1, cyclin E and CDK2. Furthermore, Wnt/β-catenin signaling had an antagonistic effect on the Notch1 signaling pathway. When the two signaling pathways were simultaneously activated, there was a combined effect of promoting the proliferation of BGC-823 cells by upregulating the expression of c-Myc, cyclin D1, cyclin E and CDK2.
Strong evidence indicates that the Wnt cascade constitutes the major driving force behind the proliferative potential of adenomas and adenocarcinomas of the stomach. Recent data indicate that active Notch signaling plays an important role in Figure 6 . Expression analysis of Notch and Wnt signaling pathway target proteins in BGC-823 cells in the presence of 1 µg/ml doxycycline and/or 10 mmol/l LiCl. β-actin was used as an internal control.
the maintenance of the undifferentiated state of gastric cells, suggesting that Notch may provide an alternative targeted-drug strategy for the treatment of gastric neoplastic diseases. A further study would be to explore the balance between the Wnt signaling cascade and Notch1 signaling pathway of gastric cancer cells.
